Cyclic melanotropins. Part VII: Modified ring structures--synthesis and biological activity

Area of Science:

• Peptide chemistry
• Endocrinology
• Pharmacology

Background:

• Alpha-melanocyte-stimulating hormone (alpha-MSH) is a potent peptide hormone.
• Cyclic analogues of alpha-MSH have been developed for enhanced stability and potency.
• Structural modifications can fine-tune the biological activity of peptide analogues.

Purpose of the Study:

• To investigate the structure-activity relationships of modified cyclic alpha-MSH analogues.
• To assess the impact of modifications at position 4 on biological activity in amphibian and reptilian models.
• To synthesize and characterize novel alpha-MSH analogues with altered structural features.

Main Methods:

• Synthesis of four cyclic alpha-MSH analogues with modifications at position 4.
• In vitro bioassays using frog and lizard skin preparations to measure melanotropic activity.
• Comparative analysis of biological activity between native and modified analogues.

Main Results:

• Removing the terminal acetylamino group ([Mpa4,Cys10]-alpha-MSH4-13-NH2) showed minimal impact on activity.
• Altering cysteine stereochemistry at position 4 (Ac-[D-Cys4,Cys10]-alpha-MSH4-a3-NH2) slightly decreased activity.
• Decreasing ring size ([Maa2,Cys10]-alpha-MSH4-13-NH2) significantly reduced activity (lizard: ~3x, frog: ~500x).
• Increasing ring size (Ac-[Hcy4,Cys10]-alpha-MSH4-13-NH2) also led to substantially lower activity, particularly in the lizard system.

Conclusions:

• Structural modifications, especially alterations in ring size and stereochemistry at position 4, critically influence the melanotropic activity of cyclic alpha-MSH analogues.
• The size of the intramolecular ring is a key determinant of biological potency in both frog and lizard bioassays.
• These findings provide insights into the pharmacophore of alpha-MSH and guide the design of future peptide-based therapeutics.